←Back to Expert Scholars
Translational Medicine / 转化医学GIST, Sarcoma Drug Development
George Demetri
MD
🏢Dana Farber Cancer Institute🌐USA
Director Sarcoma and Bone Oncology
120
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
George Demetri led landmark trials of imatinib in GIST that transformed the disease from chemotherapy refractory to highly treatable. His subsequent work established sunitinib and regorafenib in advanced GIST. He directs sarcoma and bone oncology at Dana Farber and is a global leader in sarcoma drug development.
Share:
🧪Research Fields 研究领域
GIST
imatinib
sunitinib
regorafenib
sarcoma drug development
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 George Demetri 的研究动态
Follow George Demetri's research updates
留下邮箱，当我们发布与 George Demetri（Dana Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment